Annual Cash & Cash Equivalents
$166.00 K
-$1.86 M-91.82%
December 31, 2023
Summary
- As of March 10, 2025, ALLR annual cash & cash equivalents is $166.00 thousand, with the most recent change of -$1.86 million (-91.82%) on December 31, 2023.
- During the last 3 years, ALLR annual cash & cash equivalents has fallen by -$132.00 thousand (-44.30%).
- ALLR annual cash & cash equivalents is now -99.15% below its all-time high of $19.55 million, reached on December 31, 2021.
Performance
ALLR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$18.46 M
-$770.00 K-4.00%
September 1, 2024
Summary
- As of March 10, 2025, ALLR quarterly cash and cash equivalents is $18.46 million, with the most recent change of -$770.00 thousand (-4.00%) on September 1, 2024.
- Over the past year, ALLR quarterly cash and cash equivalents has stayed the same.
- ALLR quarterly cash and cash equivalents is now -5.58% below its all-time high of $19.55 million, reached on December 31, 2021.
Performance
ALLR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ALLR Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -91.8% | 0.0% |
3 y3 years | -44.3% | 0.0% |
5 y5 years | -89.1% | 0.0% |
ALLR Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -99.2% | at low | -5.6% | >+9999.0% |
5 y | 5-year | -99.2% | at low | -5.6% | >+9999.0% |
alltime | all time | -99.2% | at low | -5.6% | >+9999.0% |
Allarity Therapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $18.46 M(-4.0%) |
Jun 2024 | - | $19.23 M(+6064.4%) |
Mar 2024 | - | $312.00 K(+88.0%) |
Dec 2023 | $166.00 K(-91.8%) | $166.00 K(-88.1%) |
Sep 2023 | - | $1.40 M(+233.1%) |
Jun 2023 | - | $420.00 K(+42.4%) |
Mar 2023 | - | $295.00 K(-85.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $2.03 M(-89.6%) | $2.03 M(-48.6%) |
Sep 2022 | - | $3.95 M(-48.6%) |
Jun 2022 | - | $7.68 M(-47.2%) |
Mar 2022 | - | $14.54 M(-25.6%) |
Dec 2021 | $19.55 M(+6462.1%) | $19.55 M(+250.2%) |
Sep 2021 | - | $5.58 M(+1773.8%) |
Dec 2020 | $298.00 K(-80.4%) | $298.00 K |
Dec 2019 | $1.52 M | - |
FAQ
- What is Allarity Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Allarity Therapeutics?
- What is Allarity Therapeutics annual cash & cash equivalents year-on-year change?
- What is Allarity Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Allarity Therapeutics?
- What is Allarity Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Allarity Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ALLR is $166.00 K
What is the all time high annual cash & cash equivalents for Allarity Therapeutics?
Allarity Therapeutics all-time high annual cash & cash equivalents is $19.55 M
What is Allarity Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ALLR annual cash & cash equivalents has changed by -$1.86 M (-91.82%)
What is Allarity Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALLR is $18.46 M
What is the all time high quarterly cash and cash equivalents for Allarity Therapeutics?
Allarity Therapeutics all-time high quarterly cash and cash equivalents is $19.55 M
What is Allarity Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ALLR quarterly cash and cash equivalents has changed by $0.00 (0.00%)